Laura Pérez Bacigalupe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Pérez Bacigalupe has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Beatriz Nieves Ureña
2 shared publicationsCristina Helguera Amezua
2 shared publicationsJesus María de la Hera Galarza
2 shared publicationsLaura López Ruiz
2 shared publications- María Fernández
Servicio de Cardiología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Asturias, Spain
2 shared publications - María Martín
Cardiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain -
2 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
Cardiovascular Complications After Kidney Transplantation: Are We Assessing the Right Aspects?
This content examines cardiovascular complications after kidney transplantation and questions the adequacy of current assessment methods.
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
Open AccessCardiovascular Complications After Kidney Transplantation: Are We Assessing the Right Aspects?
This content examines cardiovascular complications after kidney transplantation and questions the adequacy of current assessment methods.
- Open Access
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
From Pharmacological Management to Intervention: Optimising the Protocol in Kidney Transplant Candidates
This content discusses optimizing protocols for pharmacological management and interventions for kidney transplant candidates.
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
Open AccessFrom Pharmacological Management to Intervention: Optimising the Protocol in Kidney Transplant Candidates
This content discusses optimizing protocols for pharmacological management and interventions for kidney transplant candidates.
- Open Access
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
Real-world Experience with Tafamidis in Patients with Cardiac Amyloidosis
This study investigates Tafamidis's real-world effectiveness for cardiac amyloidosis patients, highlighting clinical outcomes and treatment insights.
- 15 April 2026
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- Vol. 21 (Suppl 1)
Open AccessReal-world Experience with Tafamidis in Patients with Cardiac Amyloidosis
This study investigates Tafamidis's real-world effectiveness for cardiac amyloidosis patients, highlighting clinical outcomes and treatment insights.
- Top Cited PapersOpen Access
- 13 February 2026
- Published by MDPI AG in Journal of CardioRenal Medicine
- Vol. 2 (1) , 4
Cardio-Renal Syndrome: Review and New Perspectives
Cardio-renal syndrome (CRS) is a term referring to a bidirectional group of disorders in which there is a concomitant compromise of both organs, the heart and the kidney, leading to a significant increase in morbidity and mortality. In recent years, numerous publications have addressed this complex entity from different points of view. For better understanding, five subtypes have been established: depending on its form of presentation, acute or chronic; the organ initially affected; and whether there is another responsible systemic disease. CRS represents a complex interaction between both organs with several neurohormonal, inflammatory, and hemodynamic pathophysiological mechanisms involved. Because of its heterogeneous presentation and complex management, CRS requires a multidisciplinary approach targeting multiple pathogenic mechanisms. Throughout this review, we will analyze all relevant aspects of CRS from its classification to current diagnosis and treatment. Accordingly, this review provides a holistic overview of cardio-renal syndrome, emphasizing integrated pathophysiological mechanisms, contemporary diagnostic approaches, and their relevance for clinical management.
- 13 February 2026
- Published by MDPI AG in Journal of CardioRenal Medicine
- Vol. 2 (1) , 4
Top Cited PapersOpen AccessCardio-Renal Syndrome: Review and New Perspectives
Cardio-renal syndrome (CRS) is a term referring to a bidirectional group of disorders in which there is a concomitant compromise of both organs, the heart and the kidney, leading to a significant increase in morbidity and mortality. In recent years, numerous publications have addressed this complex entity from different points of view. For better understanding, five subtypes have been established: depending on its form of presentation, acute or chronic; the organ initially affected; and whether there is another responsible systemic disease. CRS represents a complex interaction between both organs with several neurohormonal, inflammatory, and hemodynamic pathophysiological mechanisms involved. Because of its heterogeneous presentation and complex management, CRS requires a multidisciplinary approach targeting multiple pathogenic mechanisms. Throughout this review, we will analyze all relevant aspects of CRS from its classification to current diagnosis and treatment. Accordingly, this review provides a holistic overview of cardio-renal syndrome, emphasizing integrated pathophysiological mechanisms, contemporary diagnostic approaches, and their relevance for clinical management.
- Open Access
- 31 December 2025
- Published by MDPI AG in Preprints.org
Cardio-Renal Syndrome: Review and New Perspectives
Cardio-renal syndrome (CRS) is a term referring to a bidirectional group of disorders in which there is a concomitant compromise of both organs, the heart and the kidney, leading to a significant increase in morbidity and mortality. In recent years, numerous publications have addressed this complex entity from different points of view.For better understanding, five subtypes have been established: depending on its form of presentation, acute or chronic; the organ initially affected and whether there is another responsible systemic disease.CRS represents a complex interaction between both organs with several neurohormonal, inflammatory and hemodynamic pathophysiological mechanisms involved. Its different forms of presentation and the difficulty of its management requires a multidisciplinary and comprehensive therapeutic approach targeting all the mechanisms involved in its pathogenesis. Throughout this review we will analyze all relevant aspects of CRS from its classification to current diagnosis and treatment.
- 31 December 2025
- Published by MDPI AG in Preprints.org
Open AccessCardio-Renal Syndrome: Review and New Perspectives
Cardio-renal syndrome (CRS) is a term referring to a bidirectional group of disorders in which there is a concomitant compromise of both organs, the heart and the kidney, leading to a significant increase in morbidity and mortality. In recent years, numerous publications have addressed this complex entity from different points of view.For better understanding, five subtypes have been established: depending on its form of presentation, acute or chronic; the organ initially affected and whether there is another responsible systemic disease.CRS represents a complex interaction between both organs with several neurohormonal, inflammatory and hemodynamic pathophysiological mechanisms involved. Its different forms of presentation and the difficulty of its management requires a multidisciplinary and comprehensive therapeutic approach targeting all the mechanisms involved in its pathogenesis. Throughout this review we will analyze all relevant aspects of CRS from its classification to current diagnosis and treatment.